Cosmo Pharmaceuticals N.V.

Industry

  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release

Other Names/Subsidiaries

  • Aries Group, Ltd
  • Aries Pharmaceuticals, Inc.
  • BioXell
  • Cosmo Technologies Limited
  • Cosmo Pharmaceuticals S.p.A.
  • Cassiopea
See more in Biomedtracker

Latest on Cosmo Pharmaceuticals N.V.

Pink Sheet

Eli Lilly’s Alzheimer’s Drug And Italfarmaco’s Duchenne Treatment Due For Oral Explanations At EMA

 
• By Eliza Slawther and Vibha Sharma

Eli Lilly and Italfarmaco were due this week to appear before the European Medicines Agency’s human medicines committee, the CHMP, for oral explanations as to why their respective drugs, donanemab and

Generics Bulletin

Glenmark Chief On ‘Big Shift’ In Revenue By Region, Liraglutide India Outlook

 
• By Anju Ghangurde

Glenmark Pharmaceuticals Limited ’s revenue mix by region appears set for an overhaul, with Europe expected to match the US, a market where the Indian firm has been struggling to regain momentum. At t

Scrip

Glenmark Chief On ‘Big Shift’ In Revenue By Region, Liraglutide India Outlook

 
• By Anju Ghangurde

Glenmark Pharmaceuticals Limited ’s revenue mix by region appears set for an overhaul, with Europe expected to match the US, a market where the Indian firm has been struggling to regain momentum. At t

Scrip

Deal Watch: AbbVie Offloads Three Cystic Fibrosis Candidates To Sionna

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License